We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Monsanto (MON) & Pairwise to Jointly Roll Out Agro Solutions
Read MoreHide Full Article
Recently, Monsanto Company and agricultural startup firm, Pairwise Plants (Pairwise), signed a licensing and collaboration agreement in order to jointly roll out breakthrough crop-yield enhancing solutions with advanced gene-editing technology.
Through this alliance, both companies intend to introduce advanced solutions which will help improve crop harvest, guard crop from evolving threats, and aid in conversing resources that are vulnerable to extreme environmental conditions.
Per the deal, Monsanto will pay $100 million for accessing and developing Pairwise intellectual property in a series of crop applications, along with an option to commercialize the products invested from the agreement.
On the other hand, Pairwise will carve new approaches to address global food challenges via collective gene-editing technologies. Moreover, the company will develop fresh categories of gene-editing applications that will be used during the course of research under the agreement.
Our Take
Over the last three months, Monsanto’s shares have rallied 1.8%, as against the 2% loss incurred by the industry.
Stronger demand for crop-yield boosting solutions as well as new innovation investments have been bolstering revenues of this Zacks Rank #3 (Hold) company. Improved pricing for major products, like glyphosate, is expected to enhance the company’s near-term profitability. Monsanto also expects that accomplishment of Bayer AG’s (BAYRY - Free Report) buyout deal (anticipated by 2018) will open up a number of business opportunities for the company over the long term.
However, we notice that rising debt, if not checked, might drag down Monsanto’s profitability in the quarters ahead. Moreover, stiff rivalry in the seed, traits and agricultural chemical industry as well as price inflation of major inputs might also dent the company’s revenues and profitability in the near future.
Schnitzer Steel Industries, Inc. , which carries a Zacks Rank #2 (Buy), recorded an average positive earnings surprise of 0.81% over the preceding four quarters.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research. It's not the one you think.
Image: Bigstock
Monsanto (MON) & Pairwise to Jointly Roll Out Agro Solutions
Recently, Monsanto Company and agricultural startup firm, Pairwise Plants (Pairwise), signed a licensing and collaboration agreement in order to jointly roll out breakthrough crop-yield enhancing solutions with advanced gene-editing technology.
Through this alliance, both companies intend to introduce advanced solutions which will help improve crop harvest, guard crop from evolving threats, and aid in conversing resources that are vulnerable to extreme environmental conditions.
Per the deal, Monsanto will pay $100 million for accessing and developing Pairwise intellectual property in a series of crop applications, along with an option to commercialize the products invested from the agreement.
On the other hand, Pairwise will carve new approaches to address global food challenges via collective gene-editing technologies. Moreover, the company will develop fresh categories of gene-editing applications that will be used during the course of research under the agreement.
Our Take
Over the last three months, Monsanto’s shares have rallied 1.8%, as against the 2% loss incurred by the industry.
Stronger demand for crop-yield boosting solutions as well as new innovation investments have been bolstering revenues of this Zacks Rank #3 (Hold) company. Improved pricing for major products, like glyphosate, is expected to enhance the company’s near-term profitability. Monsanto also expects that accomplishment of Bayer AG’s (BAYRY - Free Report) buyout deal (anticipated by 2018) will open up a number of business opportunities for the company over the long term.
However, we notice that rising debt, if not checked, might drag down Monsanto’s profitability in the quarters ahead. Moreover, stiff rivalry in the seed, traits and agricultural chemical industry as well as price inflation of major inputs might also dent the company’s revenues and profitability in the near future.
Stocks that Warrant a Look
Two better-ranked stocks in the Zacks Basic Materials sector are listed below:
Cabot Corporation (CBT - Free Report) sports a Zacks Rank #1 (Strong Buy). The company has pulled off an average positive earnings surprise of 3.68% in the last four quarters. You can see the complete list of today’s Zacks #1 Rank stocks here.
Schnitzer Steel Industries, Inc. , which carries a Zacks Rank #2 (Buy), recorded an average positive earnings surprise of 0.81% over the preceding four quarters.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>